Propel Diabetes Research with a Comprehensive Portfolio of Immunoassays

Diabetes and Obesity Solutions 

Diabetes and obesity are complex conditions related to physiological imbalances. Researchers study many hormones to explore how pancreatic islet cell function, paracrine signaling, and energy homeostasis interplay in metabolic disorders. ALPCO’s portfolio of assays are optimized for range, sensitivity, sample type, and time. Leverage multiple formats – colorimetric or chemiluminescent ELISA, RIA – for manual or automated workflows.

  • Role of Energy Homeostasis in Diabetes
    April 20, 2023

    Understanding the Role of Energy Homeostasis in Diabetes

    Introduction The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that other parts of the body, including the cardiovascular system and kidneys, can be affected by diabetes. The key to understanding the relationship between diabetes and these other areas begins with the role of energy homeostasis in diabetes. At the same time, investig...

  • Incretins GIP and GLP-1 in Diabetes and Obesity
    April 20, 2023

    Incretins GIP and GLP-1 in Diabetes and Obesity

    800 million people worldwide struggle with obesity, a disease which will cost over $1 trillion in medical consequences by 2025.  The CDC reports that severe obesity leads to life-altering and often life-threatening conditions like heart disease, stroke, type 2 diabetes, and certain cancers. What is the “Incretin Effect”? To help understand the mechanisms behind obesity and to develop trea...
  • Diabetes and Obesity
    April 21, 2023

    Diabetes and Obesity

    Diabetes and Obesity Learning Library! As a leading provider of testing solutions for the diabetes and obesity research community, we support scientists’ efforts to gain a greater understanding of these conditions. With no cure for type 1 or type 2 diabetes and a lack of effective obesity treatments, scientists in these fields are continually in need of new methods to advance their studies. As...
  • Insulin Resistance: Root Causes, Detection, and Prevention
    November 9, 2021

    Insulin Resistance: Root Causes, Detection, and Prevention

    The Diabetes Pandemic According to the U.S. Centers for Disease Control (CDC) and the World Health Organization, more than 34 million Americans and 422 million people worldwide have diabetes.1,2 90 to 95% of people with diabetes have type 2.1 The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that more than 1 in 3 U.S. adults (~84 million) have prediabetes...

Explore all of our diabetes and obesity research

Products for Diabetes & Obesity

View as Grid List

Items 1-12 of 36

Set Descending Direction
per page

Explore all life science and clinical diagnostic specialties